跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,565 条关于
“FCS Foundation”
全部
6,565
临床试验
1,424
药物
552
机构
485
资讯
4,104
10个月前
FDA Approves First siRNA Therapy Plozasiran for Rare Metabolic Disorder Familial Chylomicronemia Syndrome
10个月前
Arrowhead Pharmaceuticals Secures First FDA Approval with Redemplo for Rare Genetic Disorder
去年
Arrowhead Pharma Focuses on Familial Chylomicronemia Syndrome with Awareness Campaign and Plozasiran Development
去年
Arrowhead Pharmaceuticals Files Patent Lawsuit Against Ionis Over Plozasiran FCS Treatment
去年
Plozasiran Shows Promise in Phase III Trial for Familial Chylomicronemia Syndrome
去年
Arrowhead Submits FDA Application for Plozasiran in Familial Chylomicronemia Syndrome
去年
Ionis' Tryngolza Approved for FCS as Arrowhead's Plozasiran Awaits FDA Review
去年
Sanofi Acquires Rights to Plozasiran for $395 Million in Greater China Deal with Arrowhead
去年
AVMF and Stanton Foundation Partner to Fund Canine Health Research with $150,000 Grant
去年
IMF and SparkCures Launch AI-Powered Clinical Trial Matching Engine for Myeloma Patients
第 1 页,共 411 页
上一页
下一页